JPRN-jRCT1091220037Other2 期
Multicenter Lymphangioleiomyomatosis Long Term Sirolimus Trial - MLLTS
Koh Nakata, MD, Ph.D0 个研究点目标入组 50 人开始时间: 2010年3月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- Other
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •1. LAM patients with definitive diagnosis.
- •2. patients who is expected to live more than two years.
- •3. patients who can visit out patient clinic periodically.
- •4. patients from whom a written informed consent will be obtained.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
A National Registry on Chinese Patients With LymphangioleiomyomatosisPulmonary FunctionNCT03193892Peking Union Medical College Hospital1,500
已完成
3 期
Efficacy and Safety of Sirolimus in LAMLymphangioleiomyomatosisNCT00414648University of Cincinnati89
已完成
不适用
Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)LeiomyomatosisNCT00001869National Heart, Lung, and Blood Institute (NHLBI)400
招募中
不适用
Japanese registry for lymphangioleiomyomatosis and alpha1-antitrypsin deficiencylymphangioleiomyomatosis and alpha1-antitrypsin deficiencyJPRN-UMIN000038966Division of Respiratory Medicine Juntendo University Faculty of Medicine & Graduate School of Medicine1,000
已完成
不适用
Pulmonary Hypertension in LymphangioleiomyomatosisPulmonary HypertensionLymphangioleiomyomatosisNCT00960895Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires20